SELMA ARZU VARDAR, ORKİDE PALABIYIK, RUHAN DENİZ TOPUZ, ELİF EZGİ GÜREL, SEMRA ÇALIŞKAN, SERAP TOPCU ÖZEN, NECDET SÜT, ÇETİN HAKAN KARADAĞ

Hemodynamic effects of atrial natriuretic peptide in ischemia-reperfusion injury that occurs after exercise

Atrial natriuretic peptide (ANP) is known as a protective agent against ischemia-reperfusion injury for cardiomyocytes. We compared the hemodynamic effects of ANP and isatin, which is known as an ANP receptor blocker, in ischemia followed by reperfusion in exercised rat hearts with nonexercised ones. Materials and methods: Isolated hearts were perfused in 4 exercised (E) groups after a running protocol for 5 days and 4 nonexercised (NE) groups. In the first protocol, ANP was added to the perfusion solution before ischemia in an E and NE group. In the second protocol, different doses of isatin (0.1, 10, 100 µM/L) were added to the perfusion solution before ANP in 3 E and 3 NE groups. Left ventricular developed pressure (LVDP) and maximum and minimum rates of change in left ventricular pressure (dP/dtmax and dP/dtmin) were recorded. Results: Higher LVDP and dP/dtmin values were observed in the E group than the NE group following addition of ANP before ischemia. Values of dP/dtmax were higher in the E group at the first minute of reperfusion period. Hemodynamic difference was not observed between groups given the same amount of isatin before ANP. Conclusion: This study indicated that higher ANP concentrations before ischemia were more effective on the left ventricle contractility and relaxation functions in the hearts that were exposed to exercise.

Anahtar Kelimeler:

Atrial natriuretic peptide, ischemia, exercise, cardiac contractility, isatin

Hemodynamic effects of atrial natriuretic peptide in ischemia-reperfusion injury that occurs after exercise

Keywords:

Atrial natriuretic peptide, ischemia, exercise, cardiac contractility, isatin,

PDF

___

1. Clerico A. Vittorini S. The cardiac natriuretic hormone system. In: Clerico A, Emdin M, editors. Natriuretic Peptides: The Hormones of the Heart. Trento, Italy: Springer-Verlag Italia; 2006. pp. 21–64.
2. Raine AE, Erne P, Bürgisser E, Müller FB, Bolli P, Burkart F, Bühler FR. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N Engl J Med 1986; 315: 533–537.
3. Karakuşoğlu Ö, Vardar SA, Kunduracılar H, Süt N. Effects of short duration supramaximal exercise on plasma atrial natriuretic peptide concentrations in healthy subjects. Turkiye Klinikleri J Sports Sci 2010; 2: 1–6.
4. Mandroukas K, Zakas A, Aggelopoulou N, Christoulas K, Abatzides G, Karamouzis M. Atrial natriuretic factor responses to submaximal and maximal exercise. Br J Sports Med 1995; 29: 248–251.
5. Onuoha GN, Nicholls DP, Patterson A, Beringer T. Neuropeptide secretion in exercise. Neuropeptides 1998; 32: 319–325.
6. Gerczuk PZ, Kloner RA. An update on cardioprotection: a review of the latest adjunctive therapies to limit myocardial infarction size in clinical trials. J Am Coll Cardiol 2012; 59: 969–978.
7. Wakui S, Sezai A, Tenderich G, Hata M, Osaka S, Taniguchi Y, Koerfer R, Minami K. Experimental investigation of direct myocardial protective effect of atrial natriuretic peptide in cardiac surgery. J Thorac Cardiovasc Surg 2010; 139: 918–925.
8. Yang XM, Philipp S, Downey JM, Cohen MV. Atrial natriuretic peptide administered just prior to reperfusion limits infarction in rabbit hearts. Basic Res Cardiol 2006; 101: 311–318.
9. Kasama S, Furuya M, Toyama T, Ichikawa S, Kurabayashi M. Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction. Eur Heart J 2008; 29: 1485–1494.
10. Sangawa K, Nakanishi K, Ishino K, Inoue M, Kawada M, Sano S. Atrial natriuretic peptide protects against ischemia-reperfusion injury in the isolated rat heart. Ann Thorac Surg 2004; 77: 233– 237.
11. Dickson EW, Hogrefe CP, Ludwig PS, Ackermann LW, Stoll LL, Denning GM. Exercise enhances myocardial ischemic tolerance via an opioid receptor-dependent mechanism. Am J Physiol Heart Circ Physiol 2008; 294: H402–408.
12. Opie LH. Ventricular function. In: Opie LH, editor. Heart Physiology from Cell to Circulation. 3rd ed. Philadelphia, PA, USA: Lippincott Williams & Wilkins; 1998. pp. 343–389.
13. Date H, Imamura T, Onitsuka H, Maeno M, Watanabe R, Nishihira K, Matsuo T, Eto T. Differential increase in natriuretic peptides in elite dynamic and static athletes. Circ J 2003; 67: 691–696.
14. Vardar SA, Aktoz M, Karakuşoğlu Ö, Kunduracilar H. The alteration of plasma atrial natriuretic peptide levels induced by postural changes in archery athletes. Trakya Univ Tıp Fak Derg 2010; 27: 275–280 (in Turkish with English abstract).
15. de Almeida JC, Alves CL, de Abreu LC, Sato MA, Fonseca FL, de Mello Monteiro CB, Vanderlei LC, Macedo H Jr, Tavares CM, Herrero D et al. Involvement of the atrial natriuretic peptide in cardiovascular pathophysiology and its relationship with exercise. Int Arch Med 2012; 5: 4.
16. Clarkson PB, Wheeldon NM, Macleod C, Coutie W, MacDonald TM. Acute effects of atrial natriuretic peptide on left ventricular diastolic function. A pulsed wave Doppler study in man. Eur Heart J 1995; 16: 1710–1715.
17. Rauch U, Schulze K, Witzenbichler B, Schultheiss HP. Alteration of the cytosolic-mitochondrial distribution of high-energy phosphates during global myocardial ischemia may contribute to early contractile failure. Circ Res 1994; 75: 760–769.
18. Gavin TP, Wagner PD. Effect of short-term exercise training on angiogenic growth factor gene responses in rats. J Appl Physiol 2001; 90: 1219–1226.
19. Demirel HA, Powers SK, Zergeroglu MA, Shanely RA, Hamilton K, Coombes J, Naito Hl. Short-term exercise improves myocardial tolerance to in vivo ischemia-reperfusion in the rat. J Appl Physiol 2001; 91: 2205–2212.
20. Diffee GM, Seversen EA, Titus MM. Exercise training increases the Ca2+ sensitivity of tension in rat cardiac myocytes. J Appl Physiol 2001; 91: 309–315.
21. Duncker DJ, Bache RJ. Regulation of coronary blood flow during exercise. Physiol Rev 2008; 88: 1009–1086.
22. Pataki I, Adamik A, Telegdy G. Isatin (indole-2,3-dione) inhibits natriuretic peptide-induced hyperthermia in rats. Peptides 2000; 21: 373–377.
23. Yang XM, Philipp S, Downey JM, Cohen MV. Atrial natriuretic peptide administered just prior to reperfusion limits infarction in rabbit hearts. Basic Res Cardiol 2006; 101: 311–318.
24. Zhong B, Wang DH. N-Oleoyldopamine, a novel endogenous capsaicin-like lipid, protects the heart against ischemiareperfusion injury via activation of TRPV1. Am J Physiol Heart Circ Physiol 2008; 295: H728–735.
25. Yaguchi Y, Satoh H, Wakahara N, Katoh H, Uehara A, Terada H, Fujise Y, Hayashi H. Protective effects of hydrogen peroxide against ischemia/reperfusion injury in perfused rat hearts. Circ J 2003; 67: 253–258.